IL6 and ischemia: One study showed that inhibiting the effects of IL-6 protein with systemic infusions of neutralizing antibodies attenuates ischemia-related increases in blood-brain barrier permeability by inhibiting IL-6, and modulates tight junction proteins after ischemia (Zhang et al., 2015b).